Search

everythinglearnresearchcommunity

for

Search:↓

The human hair follicle can store topical compounds and be targeted for drug delivery with minimal side effects.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The long-pulse alexandrite laser effectively removes hair permanently.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and inhaled budesonide.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Ruxolitinib can cause a delayed skin reaction on the nose.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

The retired colonel's ankle swelling was caused by a reaction to the antibiotic levofloxacin.

Eyelash loss can indicate various health issues, and excessive growth may be linked to certain conditions or medications; both require careful examination and tailored treatment.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Dexpanthenol improves hair growth and satisfaction in women without side effects.